Trulieve Cannabis Corp.
10.42USD
-0.5000 (-4.58%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on TRLV.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 271 | 287 | 293 | 288 | 302 | 298 | 301 | 284 |
| Cost of Revenue | 109 | 117 | 118 | 118 | 119 | 115 | 114 | 111 |
| Gross Profit | 162 | 170 | 175 | 170 | 183 | 183 | 187 | 173 |
| Operating Income | -371 | 36 | 15 | 42 | 53 | 33 | 1 | 1 |
| Net Income | -406 | 2 | -44 | -29 | -16 | -34 | -62 | -62 |
| EPS (Diluted) | — | — | — | — | — | -$0.16 | -$0.27 | -$0.32 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)